Literature DB >> 19302235

Apoptosis inducing and differentiation enhancement effect of oridonin on the all-trans-retinoic acid-sensitive and -resistant acute promyelocytic leukemia cells.

F Gao1, Q Tang, P Yang, Y Fang, W Li, Y Wu.   

Abstract

We investigated the effects of oridonin (Ori), a diterpenoid isolated from Rabdosia rubescens, on apoptosis and differentiation of all-trans-retinoic acid (ATRA)-sensitive (NB4) and ATRA-resistant (NB4-R1) cells. The results showed that reactive oxygen species initiates Ori-induced apoptosis. In addition, we found that neither Ori nor ATRA (10 nM) alone induced marked cell differentiation, while co-treatment of these two compounds can induce differentiation of NB4 and NB4-R1 cells which was accompanied by increased RARalpha, C/EBPepsilon or C/EBPbeta. This is the first report to show that RARalpha could be accumulated by Ori which may be useful as a probe to investigate the mechanism of RARalpha catabolism. These results suggest that Ori is a potential candidate for acute promyelocytic leukemia cancer therapy.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19302235     DOI: 10.1111/j.1751-553X.2009.01147.x

Source DB:  PubMed          Journal:  Int J Lab Hematol        ISSN: 1751-5521            Impact factor:   2.877


  10 in total

1.  Synergistic effect and mechanism of vitamin A and vitamin D on inducing apoptosis of prostate cancer cells.

Authors:  Jianjun Sha; Jiahua Pan; Ping Ping; Hanqing Xuan; Dong Li; Juanjie Bo; Dongming Liu; Yiran Huang
Journal:  Mol Biol Rep       Date:  2013-02-23       Impact factor: 2.316

Review 2.  Recent advances in the molecular basis of anti-neoplastic mechanisms of oridonin.

Authors:  Wei Tian; Si-Yu Chen
Journal:  Chin J Integr Med       Date:  2013-04-02       Impact factor: 1.978

3.  Oridonin induces apoptosis and senescence in colorectal cancer cells by increasing histone hyperacetylation and regulation of p16, p21, p27 and c-myc.

Authors:  Feng-Hou Gao; Xiao-Hui Hu; Wei Li; Hua Liu; Yan-Jie Zhang; Zhu-Ying Guo; Mang-Hua Xu; Shi-Ting Wang; Bin Jiang; Feng Liu; Ying-Zheng Zhao; Yong Fang; Fang-Yuan Chen; Ying-Li Wu
Journal:  BMC Cancer       Date:  2010-11-06       Impact factor: 4.430

4.  Synergistic effect of retinoic acid and vitamin D analog EB1089-induced apoptosis of hepatocellular cancer cells.

Authors:  Jianwei Zhang; Hongyan Zhang; Xia Zhang; Zhonghe Yu
Journal:  Cytotechnology       Date:  2012-10-16       Impact factor: 2.058

5.  Oridonin induces apoptosis and senescence by increasing hydrogen peroxide and glutathione depletion in colorectal cancer cells.

Authors:  Feng-Hou Gao; Feng Liu; Wei Wei; Li-Bin Liu; Mang-Hua Xu; Zhu-Ying Guo; Wei Li; Bin Jiang; Ying-Li Wu
Journal:  Int J Mol Med       Date:  2012-01-24       Impact factor: 4.101

6.  Oridonin stabilizes retinoic acid receptor alpha through ROS-activated NF-κB signaling.

Authors:  Yang Cao; Wei Wei; Nan Zhang; Qing Yu; Wen-Bin Xu; Wen-Jun Yu; Guo-Qiang Chen; Ying-Li Wu; Hua Yan
Journal:  BMC Cancer       Date:  2015-04-10       Impact factor: 4.430

7.  Combined staurosporine and retinoic acid induces differentiation in retinoic acid resistant acute promyelocytic leukemia cell lines.

Authors:  Dong-zheng Ge; Yan Sheng; Xun Cai
Journal:  Sci Rep       Date:  2014-04-28       Impact factor: 4.379

8.  Antiangiogenic effects of oridonin.

Authors:  Lili Tian; Kangjie Xie; Donglai Sheng; Xiaoqing Wan; Guofu Zhu
Journal:  BMC Complement Altern Med       Date:  2017-04-04       Impact factor: 3.659

9.  Oridonin inhibits tumor growth and metastasis through anti-angiogenesis by blocking the Notch signaling.

Authors:  Yanmin Dong; Tao Zhang; Jingjie Li; Huayun Deng; Yajuan Song; Dong Zhai; Yi Peng; Xiaoling Lu; Mingyao Liu; Yongxiang Zhao; Zhengfang Yi
Journal:  PLoS One       Date:  2014-12-08       Impact factor: 3.240

10.  Preliminary safety assessment of oridonin in zebrafish.

Authors:  Lili Tian; Donglai Sheng; Qiushuang Li; Chenxu Guo; Guofu Zhu
Journal:  Pharm Biol       Date:  2019-12       Impact factor: 3.503

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.